REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Odi Pharma Polska Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | All Other Nondepository Credit Intermediation | All Other Professional, Scientific, and Technical Services | Convention and Trade Show Organizers
Full name: Odi Pharma Polska Sp. z o.o. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Odi Pharma Polska Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was established on April 26, 2018. A growth of 5.8% was recorded in its total assets.

Headquarters
Ul. Towarowa 28
Warsaw; Mazowieckie; Postal Code: 00-839

Contact Details: Purchase the Odi Pharma Polska Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Odi Pharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Odi Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
April 26, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Odi Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
273637.44%▲
Operating profit (EBIT)
49.79%▲
Net Profit (Loss) for the Period
49.79%▲
Total assets
5.8%▲
Total equity
-69.25%▼
Return on Equity (ROE)
-87.28%▼

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
 
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
Maco Productions Polonia Sp. z o.o.
 
Orifarm Manufacturing Poland Sp. z o.o.
Direct Pharma Sp. z o.o.
 
Fortilabo Sp. z o.o.
Bloome Sp. z o.o.
 
Gazolina-Med Sp. z o.o.
Polar Snuss Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo